Prescribing for thrombophilia--are we going to repeat mistakes of the past?

Gynecol Obstet Invest. 2004;58(4):219; author reply 220. doi: 10.1159/000080418. Epub 2004 Aug 24.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Abortion, Habitual / etiology
  • Abortion, Habitual / prevention & control*
  • Antibodies, Antiphospholipid / blood
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Antiphospholipid Syndrome / complications
  • Antiphospholipid Syndrome / drug therapy
  • Aspirin / therapeutic use
  • Diethylstilbestrol / adverse effects
  • Estrogens, Non-Steroidal / adverse effects
  • Factor V / genetics
  • Female
  • Heparin / therapeutic use
  • Humans
  • Practice Patterns, Physicians' / trends*
  • Pregnancy
  • Pregnancy Outcome
  • Randomized Controlled Trials as Topic
  • Thrombophilia / complications
  • Thrombophilia / drug therapy*
  • Thrombophilia / genetics

Substances

  • Antibodies, Antiphospholipid
  • Anticoagulants
  • Estrogens, Non-Steroidal
  • factor V Leiden
  • Diethylstilbestrol
  • Factor V
  • Heparin
  • Aspirin